Targeted treatment of acute respiratory distress syndrome with statins—a commentary on two phenotype stratified re-analysis of randomized controlled trials

No immunomodulatory pharmacological interventions have been found effective for the acute respiratory distress syndrome (ARDS) despite identification of potentially effective drugs in preclinical studies (1,2).